Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Seminars in Cell & Developmental Biology|January 28, 2016
Tuberous sclerosis--A model for tumour growthKayleigh M Dodd, Elaine A DunlopCellular Signalling|March 11, 2009
Mammalian target of rapamycin complex 1-mediated phosphorylation of eukaryotic initiation factor 4E-binding protein 1 requires multiple protein-protein interactions for substrate recognitionElaine A Dunlop, Kayleigh M Dodd, Lyndsey A Seymour, et al.American Journal of Physiology. Endocrinology and Metabolism|February 23, 2012
Leucine and mTORC1: a complex relationshipKayleigh M Dodd, Andrew R TeeThe Biochemical Journal|April 15, 2017
The lysosome: a crucial hub for AMPK and mTORC1 signallingBernadette Carroll, Elaine A DunlopCancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Mechanistic target of rapamycin inhibitors: successes and challenges as cancer therapeuticsMuireann Ní Bhaoighill, Elaine A DunlopBiochemical Society Transactions|July 19, 2013
The kinase triad, AMPK, mTORC1 and ULK1, maintains energy and nutrient homoeostasisElaine A Dunlop, Andrew R TeeEuropean Journal of Human Genetics : EJHG|March 17, 2011
Determining the pathogenicity of patient-derived TSC2 mutations by functional characterization and clinical evidenceElaine A Dunlop, Kayleigh M Dodd, Stephen C Land, et al.Stem Cells (Dayton, Ohio)|October 14, 2006
Impaired downregulation following erythropoietin receptor activation in non-small cell lung carcinomaElaine A Dunlop, Alexander P Maxwell, Terence R J LappinNature Cell Biology|August 20, 2013
A tuberous sclerosis complex signalling node at the peroxisome regulates mTORC1 and autophagy in response to ROSJiangwei Zhang, Jinhee Kim, Angela Alexander, et al.Oncotarget|April 19, 2017
Targeting protein homeostasis with nelfinavir/salinomycin dual therapy effectively induces death of mTORC1 hyperactive cellsElaine A Dunlop, Charlotte E Johnson, Marie Wiltshire, et al.Pageof 3